SCENAR Therapy in Chronic Non-specific Neck Pain

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Cervicalgia, Neck Pain, Chronic Pain

In brief

Shifting away from a medication-centered approach is a major public health priority, particularly in chronic pain management, where non-pharmacological therapies are recommended despite barriers such as limited evidence and low prescriber awareness. SCENAR (Self-Controlled Energo-Neuro Adaptive Regulation), an electrotherapy device, lacks robust randomized controlled trial data. A prior study showed effects in both active and placebo groups after a single session, supporting further investigation. This study aims to assess whether repeated SCENAR sessions improve disability, mobility, and pain in patients with chronic neck pain.

Key facts

Study ID

NCT07742228

Run by

Hopital Foch

People needed

76

Starts

2026-03-11

Expected to finish

2028-07-30

Last updated by the study team

2026-08-03

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female participants aged 18 years or older
• Patients with chronic non-specific cervical spine pain, including cervicobrachial neuralgia, persisting for at least 3 months, with no identifiable underlying cause requiring specific treatment.
• Patients who attended a pain clinic consultation or were referred to a pain specialist during hospitalization.
• Neck Disability Index (NDI) score of at least 30% (≥15 points).
• Written informed consent provided prior to study participation.
• Patient affiliated to a national health insurance

You may not qualify if…

• Pregnant women
• Skin conditions preventing SCENAR use (wounds, recent scars, skin infections)
• Initiation or change of analgesic treatment within 15 days prior to inclusion or during the study
• Cervical pain related to inflammatory (spondyloarthropathy, rheumatoid arthritis, chondrocalcinosis), traumatic (fractures, dislocations), tumor-related (metastases, myeloma), infectious (spondylodiscitis), or neurological (intramedullary or posterior fossa tumor) causes
• Previous SCENAR or ECOMODYN session
• Implanted pacemaker or defibrillator
• Inability to understand French
• Adults under legal protection
• Individuals deprived of liberty or under guardianship

Where it is running

• Hôpital Foch — Suresnes, Île-de-France Region, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.